Tsuyoshi Kadosawa Selected Research

Tsuyoshi Kadosawa Research Topics

Disease

18	Neoplasms (Cancer) 02/2022 - 03/2003
4	Carcinoma (Carcinomatosis) 10/2021 - 05/2008
3	Transitional Cell Carcinoma 10/2021 - 01/2015
2	Neoplasm Metastasis (Metastasis) 10/2021 - 08/2005
2	Melanoma (Melanoma, Malignant) 09/2013 - 05/2010
2	Cysts 10/2007 - 09/2004
1	Hypoglycemia (Reactive Hypoglycemia) 03/2022
1	Carcinogenesis 12/2018
1	Lymphoma (Lymphomas) 08/2016
1	Thyroid Neoplasms (Thyroid Cancer) 06/2015
1	Cystitis 01/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2015
1	Metaplasia 05/2008
1	Ovarian Cysts (Ovarian Cyst) 10/2007
1	Sex Cord-Gonadal Stromal Tumors (Sex Cord-Stromal Tumor) 07/2007
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 07/2007
1	Dyspnea (Shortness of Breath) 06/2005
1	Cyanosis 06/2005
1	Scoliosis 04/2005
1	Syringomyelia (Morvan's Disease) 04/2005
1	Thrombosis (Thrombus) 03/2004
1	Periodontal Diseases (Periodontal Disease) 09/2003
1	Disease Progression 03/2003
1	Joint Diseases (Joint Disease) 03/2003

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 10/2021 - 09/2003
5	Messenger RNA (mRNA)IBA 01/2015 - 08/2005
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2013
2	RNA (Ribonucleic Acid)IBA 12/2018 - 08/2005
2	Vincristine (Oncovin)FDA LinkGeneric 10/2013 - 09/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2013 - 09/2013
2	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2013 - 09/2013
2	Carboplatin (JM8)FDA LinkGeneric 10/2013 - 09/2013
2	Vinblastine (Vinblastine Sulfate)FDA Link 10/2013 - 09/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2013 - 09/2013
2	Amino Acid Transport Systems (Amino Acid Transporter)IBA 09/2013 - 05/2013
2	Inhibins (Inhibin)IBA 10/2007 - 07/2007
2	placental alkaline phosphataseIBA 10/2007 - 07/2007
2	DesminIBA 10/2007 - 07/2007
1	Insulin (Novolin)FDA Link 03/2022
1	Protein Isoforms (Isoforms)IBA 10/2021
1	Epidermal Growth Factor (EGF)IBA 12/2018
1	Lapatinib (GW572016)FDA Link 12/2018
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 05/2016
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 05/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2015
1	SurvivinIBA 11/2014
1	Biological ProductsIBA 01/2014
1	Dacarbazine (DIC)FDA LinkGeneric 09/2013
1	NimustineIBA 09/2013
1	n-hexanal (hexanal)IBA 01/2013
1	Volatile Organic CompoundsIBA 01/2013
1	TolueneIBA 01/2013
1	PyrrolesIBA 01/2013
1	caprylic aldehydeIBA 01/2013
1	Verteporfin (Visudyne)FDA Link 02/2009
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2009
1	Phenobarbital (Luminal)FDA Link 05/2008
1	AntigensIBA 10/2007
1	AntibodiesIBA 10/2007
1	VimentinIBA 07/2007
1	Pharmaceutical PreparationsIBA 02/2007
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2007
1	Adenosine Triphosphate (ATP)IBA 02/2007
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2005
1	EnzymesIBA 08/2005
1	Matrix Metalloproteinases (MMPs)IBA 08/2005
1	Matrix Metalloproteinase InhibitorsIBA 08/2005
1	Histamine (Histamine Dihydrochloride)FDA Link 03/2003

Therapy/Procedure

3	Radiotherapy 08/2016 - 03/2003
3	Therapeutics 02/2009 - 03/2003
2	Semiconductor Lasers 02/2009 - 09/2004
2	Transplantation 03/2004 - 03/2003
1	Osteotomy 02/2022
1	Hemipelvectomy 02/2022
1	Thyroidectomy 06/2015
1	Anesthesia 06/2012
1	Immunotherapy 05/2010
1	Lasers (Laser) 02/2009
1	Photochemotherapy (Photodynamic Therapy) 02/2009
1	Intravenous Infusions 02/2009
1	General Anesthesia 06/2005
1	Decompression 04/2005
1	Craniotomy 04/2005
1	Laminectomy 04/2005
1	Heterologous Transplantation (Xenotransplantation) 11/2004
1	Intra-Articular Injections 03/2004
1	Neutron Capture Therapy 10/2003